Oxford Nanopore Technologies plc (ONT.L)
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
113.96+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-42.9%
The outlook
Oxford Nanopore Technologies plc currently reads as neutral based on buy — 1.8 avg of 11 analysts, below its 50- & 200-day averages, 14% of the way from its 52-week low to high, avg target +58% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 11 analysts
Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Price targetAvg target +58% vs current price
Analyst price target
~12-month · 11 analysts180.46average target+58.3% vs now
Now 113.96
Low 120.00High 225.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.11B
52-wk high
224.80
52-wk low
95.61
50-day avg
121.43
200-day avg
127.94
Trailing P/E
—